Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience

Read More

Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19

Read More

COVID-19: L’inizio di una nuova era

Autori: Fausto D’Agostino, Mario Pappagallo Formato: Volume formato 14 x 21, di 284 pagine Indice DEFINIZIONE DI PANDEMIA LA STORIA DELLA PANDEMIA SARS-COV-2 VIRUS E BATTERI LETALI COSA BISOGNA SAPERE VERO o FALSO FATTORI DI RISCHIO — Regione Sardegna, un caso particolare — La strage degli anziani e le RSA — Fumo — Ictus— Il meteo e la diffusione del virus DIAGNOSI TERAPIA — I vaccini allo studio — Farmaci — Sperimentazione immunologica — L’importanza...

Read More

Editorial – Vitamin D status

Editorial – Vitamin D status: a key modulator of innate immunity and natural defense from acute viral respiratory infections A. Fabbri, M. Infante, C. Ricordi Endocrine Unit, CTO Hospital – ASL Roma 2, Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy. andrea.fabbri@uniroma2.it DISCOVER MORE

Read More

Manuale di MEDICINA AMBULATORIALE

Medicina Ambulatoriale Questa nuova edizione del Manuale di Medicina Ambulatoriale viene pubblicata nel corso della pandemia da SARS-CoV-2 che sta mietendo un gran numero di vite umane e che ha richiesto un terribile tributo da parte dei medici e del personale sanitario. Gli aggiornamenti sulla COVID-19 sono stati effettuati fino al momento di andare in stampa anche se nuove informazioni si aggiungono ogni giorno. Inoltre, rispetto alla precedente edizione il manuale contiene numerose novità ed...

Read More

Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae

Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak D. Buonsenso, A. Piano, F. Raffaelli, N. Bonadia, K. de Gaetano Donati, F. Franceschi Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. danilo.buonsenso@policlinicogemelli.it An outbreak of a novel coronavirus disease-19 (nCoV-19) infection began in December 2019 in Wuhan, China, and now involved the whole word. Several health workers...

Read More

Eculizumab treatment in patients with COVID-19

Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience F. Diurno, F.G. Numis, G. Porta, F. Cirillo, S. Maddaluno, A. Ragozzino, P. De Negri, C. Di Gennaro, A. Pagano, E. Allegorico, L. Bressy, G. Bosso, A. Ferrara, C. Serra, A. Montisci, M. D’Amico, S. Schiano Lo Morello, G. Di Costanzo, A.G. Tucci, P. Marchetti, U. Di Vincenzo, I. Sorrentino, A. Casciotta, M. Fusco, C. Buonerba, M. Berretta, M....

Read More

COVID-19 (Novel Coronavirus 2019) – recent trends

Kannan, P. Shaik Syed Ali, A. Sheeza, K. Hemalatha School of Medicine, The Maldives National University, Male’, Maldives. Kannan.subbaram@mnu.edu.mv   INFECTIOUS DISEASES The World Health Organization (WHO) has issued a warning that, although the 2019 novel coronavirus (COVID-19) from Wuhan City (China), is not pandemic, it should be contained to prevent the global spread. The COVID-19 virus was known earlier as 2019-nCoV. As of 12 February 2020, WHO reported 45,171 cases and 1115 deaths related...

Read More

Novel coronavirus 2019-nCoV

Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV S.A. Meo, A.M. Alhowikan, T. Al-khlaiwi, I.M. Meo, D.M. Halepoto, M. Iqbal, A.M. Usmani, W. Hajjar, N. Ahmed Department of Physiology, Strategic Centre for Diabetes Research, Thoracic Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia. sultanmeo@hotmail.com   INFECTIOUS DISEASES  OBJECTIVE: Human infections with zoonotic coronavirus contain emerging and reemerging pathogenic characteristics which have raised great public health concern. This study aimed at investigating...

Read More

Novel Coronavirus 2019 (Sars-CoV2)

A global emergency that needs new approaches? Perrella, N. Carannante, M. Berretta, M. Rinaldi, N. Maturo, L. Rinaldi VII Division of Infectious Diseases and Immunology, P.O. “D. Cotugno”, AORN Ospedali dei Colli, Naples, Italy. lucarinaldi@hotmail.it   SCOPRI DI PIÚ

Read More